| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
|
J Am Geriatr Soc
|
2005
|
27.90
|
|
2
|
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.
|
Alzheimers Dement
|
2009
|
10.21
|
|
3
|
Mild cognitive impairment.
|
Lancet
|
2006
|
10.21
|
|
4
|
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
|
Nat Genet
|
2011
|
10.07
|
|
5
|
Revising the definition of Alzheimer's disease: a new lexicon.
|
Lancet Neurol
|
2010
|
8.74
|
|
6
|
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.
|
Alzheimers Dement
|
2008
|
6.39
|
|
7
|
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update.
|
J Psychosom Res
|
2002
|
4.17
|
|
8
|
Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association.
|
J Neuropsychiatry Clin Neurosci
|
2002
|
3.26
|
|
9
|
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
|
Arch Neurol
|
2006
|
3.11
|
|
10
|
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
|
Brain
|
2006
|
2.73
|
|
11
|
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease.
|
Neurobiol Aging
|
2004
|
2.23
|
|
12
|
Frontal-subcortical circuitry and behavior.
|
Dialogues Clin Neurosci
|
2007
|
2.14
|
|
13
|
Novel late-onset Alzheimer disease loci variants associate with brain gene expression.
|
Neurology
|
2012
|
2.08
|
|
14
|
Executive dysfunction and apathy predict functional impairment in Alzheimer disease.
|
Am J Geriatr Psychiatry
|
2003
|
2.07
|
|
15
|
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
|
Brain
|
2007
|
1.99
|
|
16
|
White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study.
|
Arch Neurol
|
2003
|
1.93
|
|
17
|
Management of agitation and aggression associated with Alzheimer disease.
|
Nat Rev Neurol
|
2009
|
1.86
|
|
18
|
Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
|
Am J Psychiatry
|
2003
|
1.86
|
|
19
|
A potential role of the curry spice curcumin in Alzheimer's disease.
|
Curr Alzheimer Res
|
2005
|
1.85
|
|
20
|
A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
|
Am J Psychiatry
|
2003
|
1.83
|
|
21
|
Effective pharmacologic management of Alzheimer's disease.
|
Am J Med
|
2007
|
1.79
|
|
22
|
Provisional diagnostic criteria for depression of Alzheimer disease.
|
Am J Geriatr Psychiatry
|
2002
|
1.75
|
|
23
|
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.
|
Neurobiol Aging
|
2010
|
1.70
|
|
24
|
Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature.
|
Dement Geriatr Cogn Disord
|
2007
|
1.61
|
|
25
|
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses.
|
J Alzheimers Dis
|
2010
|
1.57
|
|
26
|
Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease.
|
Arch Neurol
|
2007
|
1.55
|
|
27
|
Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms.
|
Alzheimer Dis Assoc Disord
|
2004
|
1.53
|
|
28
|
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.
|
Neuroimage
|
2010
|
1.45
|
|
29
|
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
|
Hum Brain Mapp
|
2010
|
1.40
|
|
30
|
Disease-modifying therapies in Alzheimer's disease.
|
Alzheimers Dement
|
2008
|
1.39
|
|
31
|
Neuropsychiatric symptoms and quality of life in Alzheimer disease.
|
Am J Geriatr Psychiatry
|
2005
|
1.38
|
|
32
|
Dementia with parkinsonism: what is the diagnosis?
|
Rev Neurol Dis
|
2004
|
1.38
|
|
33
|
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2007
|
1.35
|
|
34
|
Serotonin 1A receptors in the living brain of Alzheimer's disease patients.
|
Proc Natl Acad Sci U S A
|
2006
|
1.34
|
|
35
|
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families.
|
Neurogenetics
|
2006
|
1.31
|
|
36
|
Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia.
|
Mov Disord
|
2010
|
1.31
|
|
37
|
Prevalence and impact of medical comorbidity in Alzheimer's disease.
|
J Gerontol A Biol Sci Med Sci
|
2002
|
1.30
|
|
38
|
Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
|
Arch Neurol
|
2007
|
1.27
|
|
39
|
Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias.
|
J Neuropsychiatry Clin Neurosci
|
2003
|
1.27
|
|
40
|
Structural correlates of apathy in Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2007
|
1.25
|
|
41
|
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases.
|
Ann N Y Acad Sci
|
2004
|
1.23
|
|
42
|
Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia.
|
Arch Gen Psychiatry
|
2006
|
1.22
|
|
43
|
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy.
|
Neurobiol Aging
|
2010
|
1.22
|
|
44
|
Apathy symptom profile and behavioral associations in frontotemporal dementia vs dementia of Alzheimer type.
|
Arch Neurol
|
2009
|
1.17
|
|
45
|
Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.
|
Alzheimers Dement
|
2006
|
1.16
|
|
46
|
The Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer's disease.
|
J Sleep Res
|
2003
|
1.15
|
|
47
|
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).
|
Alzheimers Dement
|
2012
|
1.14
|
|
48
|
Frontal-subcortical dementias.
|
Neurologist
|
2008
|
1.14
|
|
49
|
Neuropsychiatric symptoms in the dementias.
|
Curr Opin Neurol
|
2002
|
1.13
|
|
50
|
Comorbidity in dementia: an autopsy study.
|
Arch Pathol Lab Med
|
2004
|
1.12
|
|
51
|
3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2006
|
1.06
|
|
52
|
Early-onset Alzheimer's disease is associated with greater pathologic burden.
|
J Geriatr Psychiatry Neurol
|
2007
|
1.05
|
|
53
|
Apathy and executive function in Alzheimer's disease.
|
J Int Neuropsychol Soc
|
2002
|
1.05
|
|
54
|
3D mapping of language networks in clinical and pre-clinical Alzheimer's disease.
|
Brain Lang
|
2007
|
1.05
|
|
55
|
Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis.
|
J Am Geriatr Soc
|
2003
|
1.04
|
|
56
|
Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2014
|
1.03
|
|
57
|
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.
|
Neurobiol Aging
|
2012
|
1.02
|
|
58
|
Neuropathologic correlates of apathy in Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2006
|
1.02
|
|
59
|
Toward a more precise, clinically--informed pathophysiology of pathological laughing and crying.
|
Neurosci Biobehav Rev
|
2013
|
1.01
|
|
60
|
Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2010
|
1.01
|
|
61
|
Neuropathologic correlates of activities of daily living in Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2006
|
1.00
|
|
62
|
Relative tolerability of Alzheimer's disease treatments.
|
Psychiatry (Edgmont)
|
2008
|
0.99
|
|
63
|
Current therapeutic targets for the treatment of Alzheimer's disease.
|
Expert Rev Neurother
|
2010
|
0.99
|
|
64
|
Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2012
|
0.99
|
|
65
|
Current and emerging pharmacological treatment options for dementia.
|
Behav Neurol
|
2006
|
0.98
|
|
66
|
Association of GSK3B with Alzheimer disease and frontotemporal dementia.
|
Arch Neurol
|
2008
|
0.98
|
|
67
|
Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
|
Arch Neurol
|
2012
|
0.97
|
|
68
|
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.
|
Arch Neurol
|
2005
|
0.97
|
|
69
|
Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
|
Am J Geriatr Psychiatry
|
2013
|
0.97
|
|
70
|
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria.
|
Am J Geriatr Psychiatry
|
2008
|
0.96
|
|
71
|
Speech and language in progressive nonfluent aphasia compared with early Alzheimer's disease.
|
Neurology
|
2003
|
0.96
|
|
72
|
Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease.
|
Am J Alzheimers Dis Other Demen
|
2006
|
0.96
|
|
73
|
Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men.
|
Arch Neurol
|
2005
|
0.94
|
|
74
|
Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.
|
Arch Neurol
|
2004
|
0.94
|
|
75
|
Clinical trials in predementia stages of Alzheimer disease.
|
Med Clin North Am
|
2013
|
0.94
|
|
76
|
Executive dysfunction in Alzheimer disease.
|
Arch Neurol
|
2004
|
0.94
|
|
77
|
Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
|
Neurobiol Aging
|
2012
|
0.93
|
|
78
|
Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach.
|
J Neuropsychiatry Clin Neurosci
|
2005
|
0.92
|
|
79
|
Persistence of neuropsychological testing deficits in mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2009
|
0.92
|
|
80
|
Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.
|
Curr Alzheimer Res
|
2009
|
0.91
|
|
81
|
Deficits in facial emotion processing in mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2007
|
0.91
|
|
82
|
Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.
|
Cereb Cortex
|
2010
|
0.91
|
|
83
|
Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI).
|
J Geriatr Psychiatry Neurol
|
2004
|
0.91
|
|
84
|
Dysprosodic speech following basal ganglia insult: toward a conceptual framework for the study of the cerebral representation of prosody.
|
Brain Lang
|
2005
|
0.90
|
|
85
|
Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.
|
Am J Alzheimers Dis Other Demen
|
2012
|
0.89
|
|
86
|
Practicality of a computerized system for cognitive assessment in the elderly.
|
Alzheimers Dement
|
2008
|
0.89
|
|
87
|
Relational integration and executive function in Alzheimer's disease.
|
Neuropsychology
|
2004
|
0.88
|
|
88
|
Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2011
|
0.88
|
|
89
|
Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
|
J Alzheimers Dis
|
2007
|
0.88
|
|
90
|
Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2003
|
0.88
|
|
91
|
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.
|
Arch Neurol
|
2012
|
0.87
|
|
92
|
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET.
|
Mol Genet Metab
|
2003
|
0.86
|
|
93
|
Increased prevalence of significant recurrent headache in preclinical familial Alzheimer's disease mutation carriers.
|
Dement Geriatr Cogn Disord
|
2008
|
0.86
|
|
94
|
ADCS Prevention Instrument Project: development of a brief verbal memory test for primary prevention clinical trials.
|
Alzheimer Dis Assoc Disord
|
2006
|
0.85
|
|
95
|
Frontotemporal dementia classification and neuropsychiatry.
|
Neurologist
|
2002
|
0.85
|
|
96
|
Discovering new treatments for Alzheimer's disease by repurposing approved medications.
|
Curr Top Med Chem
|
2013
|
0.85
|
|
97
|
A review: treatment of Alzheimer's disease discovered in repurposed agents.
|
Dement Geriatr Cogn Disord
|
2013
|
0.85
|
|
98
|
Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease.
|
Am J Alzheimers Dis Other Demen
|
2010
|
0.84
|
|
99
|
Neuropsychiatric symptoms, functional impairment and executive ability in Thai patients with Alzheimer's disease.
|
Int Psychogeriatr
|
2005
|
0.83
|
|
100
|
Surface feature-guided mapping of cerebral metabolic changes in cognitively normal and mildly impaired elderly.
|
Mol Imaging Biol
|
2009
|
0.83
|
|
101
|
Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia.
|
Arch Neurol
|
2003
|
0.83
|
|
102
|
Risk factors for behavioral abnormalities in mild cognitive impairment and mild Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2014
|
0.83
|
|
103
|
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease.
|
Neurobiol Aging
|
2006
|
0.82
|
|
104
|
Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.
|
Dement Geriatr Cogn Disord
|
2012
|
0.82
|
|
105
|
Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings.
|
J Neuropsychiatry Clin Neurosci
|
2002
|
0.82
|
|
106
|
Reviewing the role of donepezil in the treatment of Alzheimer's disease.
|
Curr Alzheimer Res
|
2012
|
0.81
|
|
107
|
Alzheimer's disease biomarkers: correspondence between human studies and animal models.
|
Neurobiol Dis
|
2013
|
0.80
|
|
108
|
Provisional diagnostic criteria for depression of Alzheimer's disease: description and review.
|
Expert Rev Neurother
|
2003
|
0.80
|
|
109
|
A new measurement of activities of daily living for Thai elderly with dementia.
|
Int Psychogeriatr
|
2003
|
0.80
|
|
110
|
Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2011
|
0.80
|
|
111
|
Evaluation of dementia rating scales in Parkinson's disease dementia.
|
Am J Alzheimers Dis Other Demen
|
2009
|
0.80
|
|
112
|
Measuring disease modification in Alzheimer's disease.
|
CNS Spectr
|
2007
|
0.79
|
|
113
|
Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease.
|
Neurobiol Aging
|
2007
|
0.79
|
|
114
|
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment.
|
Mol Imaging Biol
|
2002
|
0.79
|
|
115
|
The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments.
|
Neurobiol Aging
|
2013
|
0.78
|
|
116
|
The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.
|
Neuropsychiatry Neuropsychol Behav Neurol
|
2002
|
0.78
|
|
117
|
Effective and efficient diagnosis of parkinsonism: the role of dopamine transporter SPECT imaging with ioflupane I-123 injection (DaTscan™).
|
Am J Manag Care
|
2014
|
0.78
|
|
118
|
The one-minute mental status examination.
|
Neurology
|
2004
|
0.77
|
|
119
|
A videotape-based training method for improving the detection of depression in residents of long-term care facilities.
|
Gerontologist
|
2002
|
0.77
|
|
120
|
Increased fMRI signal with age in familial Alzheimer's disease mutation carriers.
|
Neurobiol Aging
|
2010
|
0.77
|
|
121
|
Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2014
|
0.77
|
|
122
|
Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.
|
Hum Brain Mapp
|
2012
|
0.77
|
|
123
|
Cholinesterase inhibitors in non-Alzheimer dementias.
|
J Am Med Dir Assoc
|
2003
|
0.77
|
|
124
|
Medical Clinics of North America. Early diagnosis and intervention in predementia Alzheimer's disease. Preface.
|
Med Clin North Am
|
2013
|
0.77
|
|
125
|
What we can learn from open-label extensions of randomized clinical trials.
|
Arch Neurol
|
2006
|
0.76
|
|
126
|
Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study.
|
Alzheimer Dis Assoc Disord
|
2013
|
0.76
|
|
127
|
Neuropsychiatric inventory workshop: behavioral and psychologic symptoms of dementia in Asia.
|
Alzheimer Dis Assoc Disord
|
2006
|
0.76
|
|
128
|
Searching for methods to detect, prevent, and treat Alzheimer's disease.
|
Am J Psychiatry
|
2005
|
0.75
|
|
129
|
Alzheimer's disease biomarkers in animal models: closing the translational gap.
|
Am J Neurodegener Dis
|
2013
|
0.75
|
|
130
|
Use of atypical antipsychotics in the elderly.
|
Psychiatry (Edgmont)
|
2008
|
0.75
|
|
131
|
Top cited papers in International Psychogeriatrics: 6b. Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease.
|
Int Psychogeriatr
|
2009
|
0.75
|
|
132
|
Dementia with parkinsonism.
|
Rev Neurol Dis
|
2004
|
0.75
|
|
133
|
The impact of depressive symptoms on patients with Alzheimer disease.
|
Alzheimer Dis Assoc Disord
|
2003
|
0.75
|
|
134
|
The role of positron emission tomography in the diagnosis of Alzheimer's disease.
|
J Am Geriatr Soc
|
2004
|
0.75
|
|
135
|
The Dementia and Disability Project in Thai Elderly: rational, design, methodology and early results.
|
BMC Neurol
|
2013
|
0.75
|
|
136
|
[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
|
Alzheimers Dement
|
2011
|
0.75
|
|
137
|
Neuropsychiatric evaluation in dementia.
|
Handb Clin Neurol
|
2008
|
0.75
|
|
138
|
Workshop reports from the third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelines.
|
Alzheimer Dis Assoc Disord
|
2006
|
0.75
|
|
139
|
The neuropsychiatric burden of neurological diseases in the elderly.
|
Int Psychogeriatr
|
2005
|
0.75
|
|
140
|
Benefit-risk considerations in the treatment of dementia with Lewy bodies.
|
Drug Saf
|
2002
|
0.75
|
|
141
|
A counseling intervention for caregivers: effect on neuropsychiatric symptoms.
|
Int J Geriatr Psychiatry
|
2004
|
0.75
|
|
142
|
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography in Alzheimer's diagnosis: time for technology transfer.
|
Mol Imaging Biol
|
2002
|
0.75
|